Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04957485
What this trial is testing

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

Who this might be right for
Smallpox
SIGA Technologies 100
Large-scale testing (Phase 3)Ended earlyNCT04572243
What this trial is testing

Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome

Who this might be right for
Epilepsies, Myoclonic
Eisai Inc. 22
Early research (Phase 1)Study completedNCT03123185
What this trial is testing

Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 91
Large-scale testing (Phase 3)Looking for participantsNCT07498426
What this trial is testing

Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals 300
Large-scale testing (Phase 3)Study completedNCT00085748
What this trial is testing

Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 114
Large-scale testing (Phase 3)Active Not RecruitingNCT04490915
What this trial is testing

Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal Hyperplasia
Neurocrine Biosciences 182
Testing effectiveness (Phase 2)Study completedNCT06306742
What this trial is testing

Open-label Placebo in Manual Therapy

Who this might be right for
Low Back Pain, Recurrent
Studio Osteopatico Busto Arsizio 31
Early research (Phase 1)Study completedNCT00499642
What this trial is testing

Study Evaluating the Effect of Lecozotan SR on the QTc Interval

Who this might be right for
Alzheimer DiseaseHealthy
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Looking for participantsNCT07090889
What this trial is testing

Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome.

Who this might be right for
Olmsted Syndrome
Orvida Pharma (formerly Kamari Pharma) 64
Early research (Phase 1)Study completedNCT04194645
What this trial is testing

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.

Who this might be right for
Healthy
Boehringer Ingelheim 66
Testing effectiveness (Phase 2)Ended earlyNCT04884295
What this trial is testing

Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19

Who this might be right for
Covid19
ExeVir Bio BV 27
Post-approval studies (Phase 4)Study completedNCT00798434
What this trial is testing

Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

Who this might be right for
Urinary Bladder, Overactive
Pfizer 794
Early research (Phase 1)Study completedNCT05163834
What this trial is testing

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

Who this might be right for
Healthy Volunteers
argenx 36
Early research (Phase 1)Study completedNCT00979316
What this trial is testing

Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects

Who this might be right for
Alzheimer Disease
Bristol-Myers Squibb 62
Not applicableStudy completedNCT02941809
What this trial is testing

Harnessing Placebo Effects in Methadone Treatment

Who this might be right for
Opioid-use DisorderOpioid-Related Disorders
University of Maryland, Baltimore 133
Testing effectiveness (Phase 2)Ended earlyNCT04852172
What this trial is testing

L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC)

Who this might be right for
Acute Vaso Occlusive Crisis (VOC)
Asklepion Pharmaceuticals, LLC 30
Early research (Phase 1)Study completedNCT03395470
What this trial is testing

Safety, Tolerability and PK of PXL770 in Healthy Male Subjects

Who this might be right for
Metabolic Disease
Poxel SA 60
Large-scale testing (Phase 3)Study completedNCT03737110
What this trial is testing

Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis

Who this might be right for
Recurrent Pericarditis
Kiniksa Pharmaceuticals (UK), Ltd. 86
Large-scale testing (Phase 3)Study completedNCT02290873
What this trial is testing

A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients

Who this might be right for
Colonoscopy
Paion UK Ltd. 461
Not applicableStudy completedNCT02578420
What this trial is testing

Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo

Who this might be right for
Placebo EffectPainExpectancy
University Hospital, Basel, Switzerland 160
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation